“Hemophagocytic Lymphohistiocytosis after EBV reactivation and ibrutinib treatment in relapsed/refractory Chronic Lymphocytic Leukemia”

Hemophagocytic Lymphohistiocytosis (HLH) is a rare syndrome characterized by ineffective T-cell and NK response. We report the clinical course of a patient with relapsed CLL who developed acute symptoms soon after starting ibrutinib. Hyperpyrexia, splenomegaly, hyperferritinemia, hypertriglyceridemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cavallari, Maurizio, Ciccone, Maria, Falzoni, Simonetta, Cavazzini, Francesco, Formigaro, Luca, Di Virgilio, Francesco, Rotola, Antonella, Rigolin, Gian Matteo, Cuneo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288319/
https://www.ncbi.nlm.nih.gov/pubmed/28180067
http://dx.doi.org/10.1016/j.lrr.2017.01.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288319/
https://www.ncbi.nlm.nih.gov/pubmed/28180067
http://dx.doi.org/10.1016/j.lrr.2017.01.002

Ejemplares similares